@FierceMedDev: Budget battles could unravel the massive device/drug user fee renewal agreed to earlier this summer. More | Follow @FierceMedDev
@MarkHFierce: Another day, another 510(k) for an Impella heart pump variation. The company is working hard to broaden its market. Release | Follow @MarkHFierce
@DamianFierce: San Antonio's BiO2 Medical pulled in $12M to market its venous catheter. News | Follow @DamianFierce
> The medical device industry has been slow to embrace sustainability or pursue the recycling of used devices, Waste & Recycling News reports. Story
> Stryker's ($SYK) interim CEO Curt Hartman says that the medical device tax will cost his company about $130 million annually, according to MassDevice. Story
> Tissue Regeneration Systems, a developer of tissue-regeneration medical devices and related equipment, has secured $1 million in new financing. Item
> China has a robust demand for certain, hospital-focused medical devices made in the U.S., Buffalo Business First explains. Story
> Endologix ($ELGX) snagged a CE mark for Nellix, a device designed to seal abdominal aortic aneurysms. Article
> As medical device companies expand into emerging markets, more and more are using overseas CROs to conduct clinical trials, according to a new study. More
> Indian devicemaker Opto Circuits snagged regulatory approval in that country for its E-Magic Plus drug-eluting stent. News
Biotech News
@FierceBiotech: What's killing biopharma's R&D success rate? Story | Follow @FierceBiotech
@JohnCFierce: AZ does a China development deal on RA drug with WuXi AppTech. Kinda similar to SFJ pacts. Look for more of these. Report | Follow @JohnCFierce
> What's killing biopharma's R&D success rate? More
> Geron in meltdown as lead cancer drug crumbles in Phase II. Report
> Atlas R&D group banks $8M in virtual development deal. Story
> Peregrine soars on promising survival data for lung cancer drug. Article
Pharma News
@FiercePharma: Truvada use expected to be limited in U.S. Story | Follow @FiercePharma
> FDA gives generic drugs 'super' status. Report
> Biogen Idec cashes out royalties on Benlysta. Article
> Budget impasse imperils FDA user fees programs. More
Biotech IT News
> Pharma flocks to social media analytics. Story
> Pinterest attracts more pharma outfits. Report
> ENCODE generates 15 trillion bytes of data for researchers. Article
> Informatics research may kill old-school databases. More
CRO News
> Top Emerging CRO Markets. Special Report
> Icon teams with Dublin university for drug development. Item
> FDA slaps DPT with warning letter over sterility concerns. Article
> CMO Patheon sells off clinical packaging biz. More